1. Gowtham, Pemula, Girigoswami, Koyeli, Thirumalai, Anbazhagan, Pallavi, Pragya, Girigoswami, Agnishwar. 2024. Association of TIMP2 418 G/C and MMP Gene Polymorphism with Risk of Urinary Cancers: Systematic Review and Meta-analysis. In Genetic testing and molecular biomarkers, 28, 83-90. doi:10.1089/gtmb.2023.0457. https://pubmed.ncbi.nlm.nih.gov/38478803/
2. Ji, M-L, Jia, J. . Correlations of TIMP2 and TIMP3 gene polymorphisms with primary open-angle glaucoma. In European review for medical and pharmacological sciences, 23, 5542-5547. doi:10.26355/eurrev_201907_18287. https://pubmed.ncbi.nlm.nih.gov/31298305/
3. Yamazaki, Tomotaka, Mimura, Imari, Kurata, Yu, Tanaka, Tetsuhiro, Nangaku, Masaomi. . Dznep, a histone modification inhibitor, inhibits HIF1α binding to TIMP2 gene and suppresses TIMP2 expression under hypoxia. In Physiological reports, 11, e15810. doi:10.14814/phy2.15810. https://pubmed.ncbi.nlm.nih.gov/37710084/
4. Chen, Wen-Quan, Yang, Su-Jin, Xu, Wen-Xiu, Wang, Dan-Dan, Tang, Jin-Hai. . Bioinformatics analysis revealing prognostic significance of TIMP2 gene in breast cancer. In Medicine, 100, e27489. doi:10.1097/MD.0000000000027489. https://pubmed.ncbi.nlm.nih.gov/34678879/